4.8 Article

Prodrug nanoassemblies bridged by Mono-/Di-/Tri-sulfide bonds: Exploration is for going further

Journal

NANO TODAY
Volume 44, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2022.101480

Keywords

Sulfur bond; Redox-responsive; Prodrugs; Self-assembly; Nanomedicines

Funding

  1. National Natural Science Foundation of China [81872816]
  2. Liaoning Revitalization Talents Program [XLYC180801]
  3. China Postdoctoral Innovative Talents Support Program [BX20190219]
  4. China Postdoctoral Science Foundation [2019M661134]
  5. Animal Ethics Committee of Shenyang Pharmaceutical University

Ask authors/readers for more resources

This study investigates the effects of sulfur bonds on prodrug nanoassemblies. It reveals that sulfur bonds significantly alter the molecular assembly of prodrugs, thereby influencing their colloidal stability and in vivo fate. Trisulfide bond is identified as a novel redox dual-sensitive linkage.
Sulfur bonds, including thioether bond and disulfide bond, have been widely used to develop tumor redoxresponsive drug delivery systems. Recently, trisulfide bond was also introduced into the construction of prodrug nanoassemblies. However, the integrated effects of these sulfur bonds on prodrug nanoassemblies remain elusive. Here, three paclitaxel homodimeric prodrugs are synthesized using thioether bond, disulfide bond or trisulfide bond as linkages. Interestingly, the sulfur bonds significantly changed the molecular assembly of prodrugs, thereby influencing the colloidal stability and in vivo destiny of prodrug nanoassemblies. More importantly, the trisulfide bond is found to be a novel redox dual-sensitive linkage, and the responsive mechanism is illustrated. The differences of thioether/disulfide/trisulfide bond are investigated in-depth, and their effect on the antitumor efficacy of prodrug nanoassemblies is also clarified. Our findings provide deep insights into the impacts of sulfur bonds on prodrug nanoassemblies, and highlight the potential of trisulfide bond for the development of redox dual-responsive nanomedicines. (c) 2022 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available